VI
Vicore Pharma Holding AB (publ)
VICO.ST · STO
10.66 kr +1.52% (+0.16 kr)
1M -8.38%
Market Cap 2.96B kr
P/E Ratio -
Div. Yield -
ROE 53.71%
Piotroski F-Score Weak
1/9Valuation
30 /100
Expensive P/B 3.46x
P/S 740.12x
P/FFO N/A
Growth
100 /100
Growing Book val. growth 55.90%
Rev. growth N/A
FCF growth N/A
Profitability
9 /100
Weak Net margin 12,569.80%
Op. margin 13,141.90%
FCF margin 7,499.05%
Quality
0 /100
Poor ROE 53.71%
ROA 53.99%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 12.68x
Int. coverage -53.72x
Debt/Equity 0.00x
Stability
1 /100
Unstable EPS volatility 126.47%
Profitable years 0
Beta 0.15x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VICO.ST
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ahmed S. Mousa
Employees
46
Headquarters
Stockholm
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report